Reviva Pharmaceuticals Holdings Inc — Quarterly Financial Statistics (NASDAQ:RVPH) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities -4.24 M-9.1 M-8.19 M-5.01 M-5.59 M -27.9 M Cash from investing activities ————— — Cash from financing activities 3.62 M17.02 M7 27110.09 M8.41 M 35.52 M Free cash flow -4.24 M-9.1 M-8.19 M-5.01 M-5.59 M -27.9 M

뉴스

브릴라록사진, 음성 바이오마커 연구에서 정신분열증 효능 입증

Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia

차단 캐피털, 레비바 파마슈티컬 주식에 ’매수’ 등급 제시

Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25 - TipRanks.com

Reviva Pharmaceuticals, H.C. Wainwright ’매수’ 등급 재확인

Reviva Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16%

레비바 제약, FDA의 2상 임상 재요청에 주가 급락

Reviva Pharmaceuticals stock plunges after FDA requests second Phase 3 trial

FDA, 레비바 정신분열증 치료제 2상 임상 권고

FDA recommends second phase 3 trial for Reviva’s schizophrenia drug